Page last updated: 2024-10-22

am 580 and Cirrhosis

am 580 has been researched along with Cirrhosis in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kobayashi, Y1
Tokuda, K1
Yamashiro, C1
Higashijima, F1
Yoshimoto, T1
Ota, M1
Ogata, T1
Ashimori, A1
Hatano, M1
Kobayashi, M1
Uchi, SH1
Wakuta, M1
Kimura, K1

Other Studies

1 other study available for am 580 and Cirrhosis

ArticleYear
Inhibition of epithelial-mesenchymal transition in retinal pigment epithelial cells by a retinoic acid receptor-α agonist.
    Scientific reports, 2021, 06-04, Volume: 11, Issue:1

    Topics: Actins; Animals; Benzoates; Cell Proliferation; Collagen; Epithelial-Mesenchymal Transition; Female;

2021